Modern Methods of Liver Fragment Vicarious Hypertrophy Stimulation prior to Advanced Resections: Assessment of Efficiency and Ways to Improve the Results
https://doi.org/10.16931/1995-5464.2016325-33
Abulkhir A., Limongelli P., Healey A.J., Damrah O., Tait P., Jackson J., Habib N., Jiao L.R. Preoperative portal vein embolization for major liver resection: A metaanalysis. Ann. Surg. 2008; 247 (1): 49–57. doi: 10.1097/ SLA.0b013e31815f6e5b.
Denys A., Prior J., Bize P., Duran R., de Baere T., Halkic N., Demartines N. Portal vein embolization: What do we know? Cardiovasc. Intervent. Radiol. 2012; 35 (5): 999–1008. doi: 10.1007/s00270-011-0300-1.
Van Lienden K.P., van den Esschert J.W., de Graaf W., Bipat S., Lameris J.S., van Gulik T.M., van Delden O.M. Portal vein embolization before liver resection: A systematic review. Cardiovasc. Intervent. Radiol. 2013; 36 (1): 25–34. doi: 10.1007/s00270-012-0440-y.
Giraudo G., Greget M., Oussoultzoglou E., Rosso E., Bachellier P., Jaeck D. Preoperative contralateral portal vein embolization before major hepatic resection is a safe and efficient procedure: a large single institution experience. Surgery. 2008; 143 (4): 476–482. doi: 10.1016/j.surg.2007.12.006.
Lee K.C., Kinoshita H., Hirohashi K., Kubo S., Iwasa R. Extension of surgical indication for hepatocellular carcinoma by portal vein embolization. World J. Surg. 1993; 17 (1): 109–115. PMID: 8383379.
Shimamura T., Nakajima Y., Une Y., Haneda T., Ogasawara K., Matsushita M., Nakanishi K. Efficacy and safety of preoperative percutaneous transhepatic portal embolization with absolute ethanol: a clinical study. Surgery. 1997; 121 (2): 135–141. PMID: 9037224.
Adam R., Lucidi V., Bismuth H. Hepatic colorectal metastases: methods of improving respectability. Surg. Clin. N. Am. 2004; 84: 659–671. doi: 10.1016/j.suc.2003.12.005.
Adam R., Miller R., Pitombo M., Wicherts D.A., de Haas R.J., Bitsakou G., Aloia T. Two-stage hepatectomy approach for initially unresectable colorectal hepatic metastases. Surg. Oncol. Clin. N. Am. 2007; 16: 525–536. doi: 10.1016/j.soc.2007.04.016.
Aussilhou B., Lesurtel M., Sauvanet A., Farges O., Dokmak S., Goasguen N., Sibert A., Vilgrain V., Belghiti J. Right portal vein ligation is as efficient as portal vein embolization to induce hypertrophy of the left liver remnant. J. Gastrointest. Surg. 2008; 12 (2): 297–303. doi: 10.1007/s11605-007-0410-x.
Capussotti L., Muratore A., Baracchi F., Lelong B., Ferrero A., Regge D., Delpero J.R. Portal vein ligation as an efficient method of increasing the future liver remnant volume in the surgical treatment of colorectal metastases. Arch. Surg. 2008; 143 (10): 978–982. doi: 10.1001/archsurg.143.10.978.
Liu H., Zhu S. Present status and future perspectives of preoperative portal vein embolization. Am. J. Surg. 2009; 197 (5): 686–690. doi: 10.1016/j.amjsurg. 2008.04.022.
Makuuchi M., Thai B.L., Takayasu K., Takayama T., Kosuge T., Gunven P., Yamazaki S., Hasegawa H., Ozaki H. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery. 1990; 107 (5): 521–527. PMID: 2333592.
Mueller L., Hillert C., Moller L., Krupski-Berdien G., Rogiers X., Broering D.C. Major hepatectomy for colorectal metastases: is preoperative portal occlusion an oncological risk factor? Ann. Surg. Oncol. 2008; 15 (7): 1908–1917. doi: 10.1245/s10434-008-9925-y.
Rous P., Larimore L. Relation of the portal blood to liver maintenance: a demonstration of liver atrophy conditional on compensation. J. Exp. Med. 1920; 31 (5): 609–637. PMID: 19868417.
Makuuchi M., Takayasu K., Takuma T. Preoperative transcatheter embolization of the portal venous branch for patients receiving extended lobectomy due to the bile duct carcinoma. J. Jap. Surg. Assoc. 1984; 45 (12): 1558–1564. doi: 10.3919/ringe1963.45.1558.
Takayasu K., Muramatsu Y., Shima Y., Moriyama N., Yamada T., Makuuchi M. Hepatic lobar atrophy following obstruction of the ipsilateral portal vein from hilar cholangiocarcinoma. Radiology. 1986; 160 (2): 389–393. doi: 10.1148/radiology.160.2.3014598.
Kinoshita H., Sakai K., Hirohashi K., Igawa S., Yamasaki O., Kubo S. Preoperative portal vein embolization for hepatocellular carcinoma. World J. Surg. 1986; 10 (5): 803–808. PMID: 3022488.
Baumgart J., Lang S., Lang H. A new method for induction of liver hypertrophy prior to right trisectionectomy: a report of three cases. HPB (Oxford). 2011; 13 (Suppl. 2): 71–72.
Schnitzbauer A.A., Lang S.A., Goessmann H., Nadalin S., Baumgart J., Farkas S.A., Fichtner-Feigl S., Lorf T., Goralcyk A., Horbelt R., Kroemer A., Loss M., Rummele P., Scherer M.N., Padberg W., Konigsrainer A., Lang H., Obed A., Schlitt H.J. Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. Ann. Surg. 2012; 255 (3): 405–414. doi: 10.1097/SLA.0b013e31824856f5.
Broering D.C., Hillert C., Krupski G., Fischer L., Mueller L., Achilles E.G., Schulte A.M., Esch J., Rogiers X. Portal vein embolization vs. portal vein ligation for induction of hypertrophy of the future liver remnant. J. Gastrointest. Surg. 2002; 6 (6): 905–913. doi: 10.1016/S1091-255X(02)00122-1.
Perarnau J.M., Daradkeh S., Johann M., Deneuville M., Weinling P., Coniel C. Transjugular preoperative portal embolization (TJPE): a pilot study. Hepatogastroenterology. 2003; 50 (51): 610–613. PMID: 12828044.
Lim C., Farges O. Portal vein occlusion before major hepatectomy in patients with colorectal liver metastases: rationale, indications, technical aspects, complications and outcome. J. Vasc. Surg. 2012; 149 (2): 86–96. doi: 10.1016/j.jviscsurg.2012.03.003.
Lindner P., Cahlin C., Friman S., Hafstrom L., Klingenstierna H., Lonn L., Olausson M., Rizell M. Extended right-sided liver resection for colorectal liver metastases-impact of percutaneous portal venous embolisation. Eur. J. Surg. Oncol. 2006; 32 (3): 292–296. doi: http://dx.doi.org/10.1016/j.ejso.2005.12.007.
Pamecha V., Levene A., Grillo F., Woodward N., Dhillon A., Davidson B.R. Effect of portal vein embolisation on the growth rate of colorectal liver metastases. Br. J. Cancer. 2009; 100 (4): 617–622. doi: 10.1038/sj.bjc.6604872.
Denys A.L., Abehsera M., Leloutre B., Sauvanet A., Vilgrain V., O’Toole D., Belghiti J., Menu Y. Intrahepatic hemodynamic changes following portal vein embolization: a prospective Doppler study. Eur. Radiol. 2000; 10 (11): 1703–1707. doi: 10.1007/s003300000577.
Yokoyama Y., Nagino M., Nimura Y. Mechanisms of hepatic regeneration following portal vein embolization and partial hepatectomy: a review. World J. Surg. 2007; 31 (2): 367–374. doi: 10.1007/s00268-006-0526-2.
Kokudo N., Tada K., Seki M., Ohta H., Azekura K., Ueno M., Ohta K., Yamaguchi T., Matsubara T., Takahashi T., Nakajima T., Muto T., Ikari T., Yanagisawa A., Kato Y. Proliferative activity of intrahepatic colorectal metastases after preoperative hemihepatic portal vein embolization. Hepatology. 2001; 34 (2): 267–272. doi: 10.1053/jhep.2001.26513.
Kollmar O., Corsten M., Scheuer C., Vollmar B., Schilling M.K., Menger M.D. Tumour growth following portal branch ligation in an experimental model of liver metastases. Br. J. Surg. 2010; 97 (6): 917–926. doi: 10.1002/bjs.7003.
Mueller L., Grotelueschen R., Meyer J., Vashist Y.K., Abdulgawad A., Wilms C., Hillert C., Rogiers X., Broering D.C. Sustained function in atrophying liver tissue after portal branch ligation in the rat. J. Surg. Res. 2003; 114 (2): 146–155. doi: 10.1016/S0022-4804(03)00252-X.
Nabeshima K., Shimano Y., Inoue T., Itoh H., Kataoka H., Koono M. Hepatocyte growth factor/scatter factor induces not only scattering but also cohort migration of human colorectal adenocarcinoma cells. Int. J. Cancer. 1998; 78 (6): 750–759. doi: 10.1002/(SICI)1097-0215(19981209)78:6<750::AIDIJC13>3.0.CO;2-#.
Uemura T., Miyazaki M., Hirai R., Matsumoto H., Ota T., Ohashi R., Shimizu N. Different expression of positive and negative regulators of hepatocyte growth in growing and shrinking hepatic lobes after portal vein branch ligation in rats. Int. J. Mol. Med. 2000; 5 (2): 173–179. doi: 10.11501/3168376.
Ciocca D.R., Calderwood S.K. Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones. 2005; 2 (10): 86–103. doi: 10.1379/CSC-99r.1.
Shindon J., Vauthey J.N., Zimmitti G., Curley S.A., Huang S.Y., Mahvash A., Gupta S., Wallace M.J., Aloia T.A. Analysis of the efficacy of portal vein embolization for patients with extensive liver malignancy and very low future liver remnant volume, including a comparison with the associating liver partition with portal vein ligation for staged hepatectomy approach. J. Am. Coll. Surg. 2013; 217 (1): 126–133. doi: 10.1016/j.jamcollsurg.2013.03.004
Alvarez F.A., Iniesta J., Lastiri J., Ulla M., Bonadeo Lassalle F., de Santibanes E. New method of hepatic regeneration. Cir. Esp. 2011; 89 (10): 645–649. doi: 10.1016/j.ciresp.2011.08.001
De Santibañes E., Clavien P.A. Playing Play-Doh to prevent postoperative liver failure. The “ALPPS” approach. Ann. Surg. 2012; 255 (3): 415–417. doi: 10.1097/SLA.0b013e318248577d
De Santibañes E., Alvarez F.A., Ardiles V. How to avoid postoperative liver failure: a novel method. World J. Surg. 2012; 36 (1): 125–128. doi: 10.1007/s00268-011-1331-0.
Abstract
Aim. To assess an efficiency of modern methods of vicarious hypertrophy stimulation of the remnant liver after advanced
resection and to reduce the risk of postoperative liver failure.
Material and Methods. Programmed stimulation of liver vicarious hypertrophy was applied in 119 patients including ligation and transection of portal vein branches in 76 patients (64.8%), endovascular embolization of portal vein branches in 21 patients (17.6%), endovascular embolization of the portal vein combined with chemoembolization of the hepatic artery in 15 patients (12.7%), and split in situ liver resection in 7 patients (5.9%). Volume of remnant liver was measured using computerized tomography, magnetic resonance imaging and/or ultrasound prior to and in 2–4 weeks after occlusion of portal vein branches.
Results. According to CT/MRI data remnant liver volume increased from 28.4% to 48.7% (by 38.9 ± 5.5% on the average). 72 patients (60.5%) were operated: right-sided or extended right-sided hemihepatectomies were performed in 49 cases (68%), atypical liver resection – in 21 cases (29.2%). Postoperative complications were registered in 16 cases (22%). Mortality due to post-resection hepatic failure was 2.8%. Liver resection was not performed in 47 cases (39.5%) due to insufficient increase of liver fragment, newly diagnosed intrahepatic metastases or local recurrence of colorectal cancer.
Conclusion. Preoperative programmed stimulation of liver fragment is a perspective method that increases percent of operable patients with liver tumors and reduces the risk of hepatic failure after extensive liver resection. Surgical and endovascular methods of preoperative programmed stimulation of liver vicarious hypertrophy are technically feasible and safe.
About the Authors
E. M. Zagainov
Federal Budget-Funded Institution of Health “Volga District Medical Center” of the Federal Medical and Biological Agency of Russia
Russian Federation
Medical Specialist in Endovascular Diagnostics and Treatment, Clinical Hospital No.1, Volga District Medical Center of the Federal Medical and Biological Agency of Russia
A. A. Seregin
Federal Budget-Funded Institution of Health “Volga District Medical Center” of the Federal Medical and Biological Agency of Russia
Russian Federation
Chief of the Department of Endovascular Diagnostics and Treatment
A. I. Zaytsev
Federal Budget-Funded Institution of Health “Volga District Medical Center” of the Federal Medical and Biological Agency of Russia
Russian Federation
Medical Specialist in Endovascular Diagnostics and
Treatment
D. V. Komarov
Federal Budget-Funded Institution of Health “Volga District Medical Center” of the Federal Medical and Biological Agency of Russia
Russian Federation
Cand. of Med. Sci.
E. G. Sharabrin
Federal Budget-Funded Institution of Health “Volga District Medical Center” of the Federal Medical and Biological Agency of Russia; State Budget-Funded Educational Institution of Higher Professional Education “Nizhny Novgorod State Medical Academy” of the Ministry of Health of the Russian Federation
Russian Federation
Doct. of Med. Sci., Professor of the Department of X-Ray Diagnostics, Faculty for Advanced Training of Physicians
P. I. Rykhtik
Federal Budget-Funded Institution of Health “Volga District Medical Center” of the Federal Medical and Biological Agency of Russia
Russian Federation
Cand. of Med. Sci., Chief Specialist in X-ray Diagnostics
V. M. Kukosh
Federal Budget-Funded Institution of Health “Volga District Medical Center” of the Federal Medical and Biological Agency of Russia
Russian Federation
Surgeon at the Clinical Hospital No. 1, Volga District Medical Center of the Federal Medical and Biological Agency of Russia
V. E. Zagainov
Federal Budget-Funded Institution of Health “Volga District Medical Center” of the Federal Medical and Biological Agency of Russia; State Budget-Funded Educational Institution of Higher Professional Education “Nizhny Novgorod State Medical Academy” of the Ministry of Health of the Russian Federation
Russian Federation
Doct. of Med. Sci., Chief Surgical Specialist
References
1. Гранов А.М., Давыдов М.И. Интервенционная радиология в онкологии. СПб.: Фолиант, 2013. 560 с. Granov А.М., Davidov М.I. Interventsionnaya radiologiya v onkologii [Interventional radiology in oncology]. St.-Peterburg: Publishing House Foliant, 2013. 560 p. (In Russian)
2. Вишневский В.А., Назаренко Н.А., Икрамов Р.З., Тарасюк Т.И. Пути улучшения результатов обширных резекций печени. Анналы хирургической гепатологии. 2005; 10 (1): 12–17. Vishnevsky V.A., Nazarenko N.A., Ikramov R.Z., Tarasyuk T.I. Ways to improve the results of advanced liver resections. Annaly khirurgicheskoy gepatologii. 2005; 10 (1): 12–17. (In Russian)
3. Таразов П.Г., Гранов Д.А., Сергеев В.И., Поликарпов А.А., Полысалов В.Н., Розенгауз Е.В. Предоперационная эмболизация воротной вены при злокачественных опухолях пе чени. Анналы хирургической гепатологии. 2002; 7 (1): 7–13. Tarazov P.G., Granov D.A., Sergeev V.I., Polikarpov A.A., Polysalov V.N., Rozengauz E.V. Preoperative portal vein embolization for malignant liver tumors. Annaly khirurgicheskoy gepatologii. 2002; 7 (1): 7–13. (In Russian)
4. Скипенко О.Г., Беджанян А.Л., Багмет Н.Н., Шатверян Г.А., Полищук Л.О., Чардаров Н.К. Новый подход к двухэтапным операциям на печени (In Situ Splitting). Хирургия. 2013; 3: 37–41. Skipenko O.G., Bedzhanyan A.L., Bagmet N.N., Shatveryan G.A., Polishchuk L.O., Chardarov N.K. A new approach to the two-stage liver surgery (In Situ Splitting). Khirurgiya. 2013; 3: 37–41. (In Russian)
5. Полищук Л.О., Скипенко О.Г., Абдуллаев А.Г., Поляков Р.С., Секачева М.И., Шатверян Г.А., Бирюков А.Ю., Скипенко Т.О. Прогрессирование метастатического колоректального рака после окклюзии правой ветви воротной вены. Хирургия. 2011; 10: 4–12. Polishchuk L.O., Skipenko O.G., Abdullayev A.G., Polyakov R.S., Sekacheva M.I., Shatveryan G.A., Biryukov A.Yu., Skipenko T.O. The progression of metastatic colorectal cancer after occlusion of the right branch of the portal vein. Khirurgiya. 2011; 10: 4–12. (In Russian)
6. Чайченко Д.В., Важенин А.В., Привалов А.В., Надвикова Е.А. Первый опыт использования на Урале двухэтапной методики резекции печени (Split in situ) при обширном метастатическом поражении. Сибирский онкологический журнал. 2013; 58 (4): 66–68. Chaychenko D.V., Vazhenin A.V., Privalov A.V., Nadvikova E.A. The first experience of two-stage liver resection (Split in situ) with extensive metastatic disease in the Urals. Sibirskii onkologicheskii zhurnal. 2013; 58 (4): 66–68. (In Russian)
For citations:
Zagainov E.M.,
Seregin A.A.,
Zaytsev A.I.,
Komarov D.V.,
Sharabrin E.G.,
Rykhtik P.I.,
Kukosh V.M.,
Zagainov V.E.
Modern Methods of Liver Fragment Vicarious Hypertrophy Stimulation prior to Advanced Resections: Assessment of Efficiency and Ways to Improve the Results. Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery. 2016;21(3):25-33.
(In Russ.)
https://doi.org/10.16931/1995-5464.2016325-33
Views:
1805